相关实验视频
Updated: Jun 19, 2026

11:51
Facile Preparation of 4-Substituted Quinazoline Derivatives
Published on: February 15, 2016
11.8K
作为潜在的mTOR抑制剂的Morpholine-Substituted Tetrahydroquinoline衍生物:合成,计算洞察力和细胞分析
Rajdeep Dey1, Suman Shaw1, Ruchi Yadav2
1Department of Pharmaceutical Chemistry, Institute of Pharmacy, Nirma University, Ahmedabad 382481, Gujarat, India.
Cancers
|March 13, 2025
概括
新型四基诺林 (THQ) 衍生物显示出强大的抗癌活性,特别是化合物10e,针对mTOR途径进行潜在的肺癌疗法.
科学领域:
- 药用化学 医学化学
- 分子药理学分子药理学
- 药物发现 药物发现 药物发现
背景情况:
- 向性癌症治疗需要新的抑制机械向性拉巴胺素 (mTOR) 途径的新型抑制剂.
- 目前,四基诺林 (THQ) 衍生物正在研究其作为mTOR抑制剂的潜力.
研究的目的:
- 设计,合成和评估新型THQ衍生物作为针对癌症治疗的潜在mTOR抑制剂.
- 研究这些化合物的抗癌活性和作用机制.
主要方法:
- 合成了八种新的THQ衍生品.
- 使用质谱学和NMR (H,C) 的表征.
- 在体外细胞毒性测试,分子对接和分子动力学 (MD) 模拟.
主要成果:
- 化合物10e在体外对三阴性乳腺癌,肺癌和乳腺癌细胞系表现出显著的细胞毒性 (IC50 = 0.033μM对A549细胞).
- 分子对接和MD模拟显示,在mTOR活性位点内的衍生物具有强烈的结合亲和力和稳定性.
- 三甲基和形态素部分增强了化合物的选择性和效力,对健康细胞的影响最小.
结论:
- 化合物10e是一种非常有前途的mTOR抑制剂候选者,用于向癌症治疗,特别是肺癌.
- THQ衍生物,特别是化合物10e,表现出强大和选择性的抗癌作用,诱导细胞亡.
- MD模拟证实了稳定的相互作用,支持这些THQ衍生物的治疗潜力.
相关概念视频
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...

